Acetylsalicylic acid Completed Phase 4 Trials for Coronary Heart Disease (CHD) / Platelet Aggregation Inhibitors Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00799396Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)